The store will not work correctly when cookies are disabled.
2-(6-(3-(difluoromethyl)-4-fluorophenyl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-N,N-dimethylacetamide
ID: ALA4547576
PubChem CID: 155553391
Max Phase: Preclinical
Molecular Formula: C18H16F3N3O
Molecular Weight: 347.34
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C)C(=O)Cn1ccc2ncc(-c3ccc(F)c(C(F)F)c3)cc21
Standard InChI: InChI=1S/C18H16F3N3O/c1-23(2)17(25)10-24-6-5-15-16(24)8-12(9-22-15)11-3-4-14(19)13(7-11)18(20)21/h3-9,18H,10H2,1-2H3
Standard InChI Key: DNBUFJYOCPLTQY-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
14.6255 -9.3812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6243 -10.2007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3324 -10.6097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3306 -8.9723 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.0392 -9.3776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0440 -10.1962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8240 -10.4446 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.3014 -9.7795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8163 -9.1201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0811 -11.2203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8814 -11.3856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1384 -12.1613 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.4247 -10.7751 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.5952 -12.7718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9387 -12.3266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9163 -10.6087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2105 -10.1981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5030 -10.6055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5019 -11.4236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2143 -11.8326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9189 -11.4228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7944 -11.8325 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
13.2165 -12.6497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5099 -13.0603 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
13.9253 -13.0564 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
7 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
12 15 1 0
2 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
19 22 1 0
20 23 1 0
23 24 1 0
23 25 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 347.34 | Molecular Weight (Monoisotopic): 347.1245 | AlogP: 3.87 | #Rotatable Bonds: 4 |
Polar Surface Area: 38.13 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.34 | CX LogP: 2.76 | CX LogD: 2.76 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.72 | Np Likeness Score: -1.87 |
References
1. Chrovian CC, Soyode-Johnson A, Wall JL, Rech JC, Schoellerman J, Lord B, Coe KJ, Carruthers NI, Nguyen L, Jiang X, Koudriakova T, Balana B, Letavic MA.. (2019) 1H-Pyrrolo[3,2-b]pyridine GluN2B-Selective Negative Allosteric Modulators., 10 (3): [PMID:30891123] [10.1021/acsmedchemlett.8b00542] |